Emil Billbck - Bonesupport Holding Chief Officer

BONEX Stock  SEK 371.80  3.00  0.81%   

Insider

Emil Billbck is Chief Officer of Bonesupport Holding AB
Age 53
Phone46 4 62 86 53 70
Webhttps://www.bonesupport.com

Bonesupport Holding Management Efficiency

The company has return on total asset (ROA) of (0.1349) % which means that it has lost $0.1349 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2528) %, meaning that it generated substantial loss on money invested by shareholders. Bonesupport Holding's management efficiency ratios could be used to measure how well Bonesupport Holding manages its routine affairs as well as how well it operates its assets and liabilities.
Bonesupport Holding AB has accumulated 16.15 M in total debt with debt to equity ratio (D/E) of 6.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bonesupport Holding has a current ratio of 3.71, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Bonesupport Holding until it has trouble settling it off, either with new capital or with free cash flow. So, Bonesupport Holding's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bonesupport Holding sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bonesupport to invest in growth at high rates of return. When we think about Bonesupport Holding's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Johan HolmstromXvivo Perfusion AB
53
Charlotte WalldalXvivo Perfusion AB
56
Annette MattssonCamurus AB
57
Johanna FltingBioArctic AB
51
Andreas MDXvivo Perfusion AB
46
Pr GellerforsBioArctic AB
76
Jeffrey BerkleySurgical Science Sweden
54
Oskar BossonBioArctic AB
47
Inbal MazorBadichiSurgical Science Sweden
54
Jaya TiwariXvivo Perfusion AB
N/A
Gisli HennermarkSurgical Science Sweden
51
Martin JanssonSurgical Science Sweden
52
AdvSurgical Science Sweden
55
Gunilla AnderssonBioArctic AB
62
Daniel EvestedtSurgical Science Sweden
46
Ran BronsteinSurgical Science Sweden
59
Doron ZilbermanSurgical Science Sweden
61
Jon AlonsoCamurus AB
50
Maria LundqvistCamurus AB
57
Pr LannfeltBioArctic AB
74
Lena BScXvivo Perfusion AB
58
Bonesupport Holding AB , an orthobiologics company, develops and commercializes injectable bioceramic bone graft substitutes for the treatment of bone voids Sweden and internationally. The company was founded in 1999 and is headquartered in Lund, Sweden. BONESUPPORT HOLDING operates under Medical Instruments Supplies classification in Sweden and is traded on Stockholm Stock Exchange. It employs 78 people. Bonesupport Holding AB (BONEX) is traded on Stockholm Exchange in Sweden and employs 92 people.

Management Performance

Bonesupport Holding Leadership Team

Elected by the shareholders, the Bonesupport Holding's board of directors comprises two types of representatives: Bonesupport Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bonesupport. The board's role is to monitor Bonesupport Holding's management team and ensure that shareholders' interests are well served. Bonesupport Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bonesupport Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jerry Chang, Executive Vice President of Research & Development
AnnMarie Thor, Acting Marketing
Kristina Ingvar, Ex Affairs
Michael Roth, GM America
Prof MD, Founder Director
Fergus MacLeod, GM EUROW
Michael MD, Ex Officer
Emil Billbck, Chief Officer
Hkan Johansson, Chief Officer
Helena Brandt, Head of Human Resources

Bonesupport Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bonesupport Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bonesupport Stock Analysis

When running Bonesupport Holding's price analysis, check to measure Bonesupport Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bonesupport Holding is operating at the current time. Most of Bonesupport Holding's value examination focuses on studying past and present price action to predict the probability of Bonesupport Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bonesupport Holding's price. Additionally, you may evaluate how the addition of Bonesupport Holding to your portfolios can decrease your overall portfolio volatility.